Published: Jun 14, 2026
Written by Klarity Editorial Team
Published: Jun 14, 2026

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can prescribe medications remotely in 2026, the short answer is: yes, with caveats. Telepsychiatry has gone from emergency stopgap to standard practice, but the rules around prescribing—especially controlled substances like Adderall, Xanax, or Suboxone—are still evolving. Federal waivers, state-specific telehealth laws, and scope-of-practice differences between MDs and NPs all factor into what you can and cannot do.
This guide breaks down the current landscape: what psychiatrists can prescribe via telehealth, how PMHNP authority differs by state, and what you need to know to stay compliant while serving patients remotely.
The big question for most psychiatric prescribers: Can I start a new patient on a Schedule II stimulant or benzodiazepine without seeing them in person?
As of early 2026, yes—under a temporary federal waiver. The DEA extended its COVID-era telemedicine flexibility through December 31, 2025, allowing prescribers to initiate controlled substances (including Schedule II drugs like Adderall or Ritalin) via audio-visual telehealth without an initial in-person exam. This waiver has been a lifeline for ADHD and anxiety treatment, enabling psychiatrists to manage these conditions entirely online.
But this isn’t permanent. The DEA has proposed new rules that could reimpose in-person requirements—possibly with exceptions for 30-day supply limits, referrals from in-person clinicians, or special DEA telehealth registrations. The final rule hasn’t landed yet, so providers should monitor DEA announcements closely. For now, though, you can legally prescribe controlled substances to new patients via secure video in compliance with federal law.
State-level nuances matter too. While federal law sets the floor, some states have their own telehealth prescribing rules that can be more restrictive—or more permissive. Let’s look at how key states handle this.
Psychiatrists (MD/DO): Texas allows telemedicine prescribing of controlled substances for psychiatric treatment, as long as you conduct a valid audio-visual exam that meets the standard of care. You cannot prescribe opioids for chronic pain via telehealth (that requires in-person), but ADHD stimulants, anti-anxiety meds, and buprenorphine for opioid use disorder are all fair game under the current federal waiver.
Texas law requires you to check the Prescription Monitoring Program (PMP) before prescribing any controlled substance—telehealth or not. This is non-negotiable and applies to every controlled Rx you write.
PMHNPs: Texas is a restricted practice state—nurse practitioners cannot prescribe independently. Every PMHNP must have a Prescriptive Authority Agreement with a Texas-licensed physician to prescribe anything, including psychiatric medications.
Here’s where it gets tricky: Texas law generally prohibits NPs from prescribing Schedule II controlled substances in outpatient settings, with narrow exceptions (hospice, terminal illness, or very specific ADHD treatment protocols for children). In practice, many Texas PMHNPs defer Schedule II stimulants to their supervising psychiatrist, or work in settings where the physician writes the initial prescription.
This creates a real bottleneck—Texas has some of the worst psychiatrist shortages in the country (1 psychiatrist per ~8,500 residents), yet NPs can’t fully step in to fill the gap. If you’re a PMHNP in Texas, expect to collaborate closely with a physician and navigate these prescribing limits carefully.
Psychiatrists: Florida is one of the most permissive states for telehealth prescribing of controlled substances—if you’re treating a psychiatric disorder. Florida law explicitly allows teleprescribing of controlled substances for mental health treatment, which means you can start a patient on Adderall or Xanax via video without an in-person visit. This carve-out doesn’t apply to chronic pain management (that still requires in-person), but for psychiatry, you’re good to go.
PMHNPs: Florida recently granted ‘autonomous practice’ status to some NPs—but psychiatric NPs were excluded. PMHNPs in Florida still need a supervising physician (ideally a psychiatrist) and a written protocol to prescribe.
There’s a silver lining: Florida defines a ‘psychiatric nurse’ (PMHNP with ≥2 years of experience under a psychiatrist) who can prescribe psychotropic controlled substances without the usual 7-day Schedule II limit that applies to other NPs. But you still need that collaboration agreement, and you still can’t practice independently.
For a Florida PMHNP, this means finding a collaborating psychiatrist is essential—and in a state with 7.8 million people living in mental health shortage areas, that’s not always easy.
Psychiatrists: New York aligns with federal telehealth rules and recently finalized state regulations to permit controlled substance prescribing via telemedicine when consistent with federal law. In practice, this means you can prescribe as you would in-person, with the added requirement to check the state’s PMP (I-STOP registry) before any Schedule II–IV prescription.
PMHNPs: New York offers a transition-to-independence model. New NPs must practice under a collaborative agreement with a physician for their first 3,600 hours (roughly 2 years full-time). After that, they can practice independently—no written agreement, no chart review, no physician oversight.
This has made New York one of the more NP-friendly states in the Northeast. Experienced PMHNPs in NY can open their own practices, prescribe independently (including controlled substances), and serve underserved upstate regions where psychiatrists are scarce. If you’re an NP starting out, those first two years require supervision—but after that, you’re essentially practicing like a physician (under nursing board authority).
Psychiatrists: California permits prescribing via telehealth after a ‘good faith exam’—which explicitly includes telehealth exams. You must check CURES (California’s PMP) before prescribing Schedule II–IV drugs, but otherwise, you can prescribe psychiatric medications remotely with no special restrictions.
PMHNPs: California is mid-transition to full practice authority via AB 890. As of 2023, NPs with ≥3 years of experience can become ‘103 NPs’ and practice without physician supervision in group settings. Starting January 1, 2026, experienced NPs can apply for ‘104 NP’ status—full independent practice, including solo practice and prescribing, with zero physician oversight.
New NPs still need to work under physician-supervised standardized procedures for at least 3 years, but the pathway to autonomy is clear. By 2026, California will effectively be a full practice authority state for experienced PMHNPs, which is a huge shift in the nation’s most populous state.
Psychiatrists: No restrictions—you can prescribe via telehealth under federal allowances.
PMHNPs: Pennsylvania requires a collaborative agreement indefinitely. There’s no pathway to independence yet, though legislation has been introduced. PMHNPs must have a physician co-sign a certain percentage of charts (often 10% quarterly), and Schedule II prescriptions are limited to 30-day supplies with physician notification within 24 hours.
Many PA NPs work for healthcare systems or telehealth companies that provide the collaborating physician as part of the employment package. If you’re an independent-minded PMHNP, Pennsylvania isn’t the place—yet. Watch for legislative changes, as neighboring states (NY, OH) have moved to grant full practice authority recently.
Psychiatrists: Illinois allows telehealth prescribing under federal guidelines. Private payers are required to reimburse telehealth at parity through at least 2027, making Illinois a good market for telepsychiatry.
PMHNPs: Illinois requires 4,000 hours of collaboration plus 250 hours of continuing education before granting Full Practice Authority. Until then, NPs must have a written collaborative agreement, and their prescriptions are technically under the delegating physician’s authority (the physician’s name goes on the script).
Once you achieve FPA licensure, you can prescribe independently, including controlled substances. This transition period is longer than New York’s but still offers a clear endpoint. Illinois also uniquely allows specially trained clinical psychologists to prescribe a limited mental health formulary—a nod to the state’s serious psychiatrist shortage (291 practitioners needed to eliminate mental health HPSAs).
| State | Psychiatrist (MD/DO) | PMHNP Authority | Key Restrictions for NPs |
|---|---|---|---|
| California | Independent, full authority | Transitioning to FPA (full by 2026 for experienced NPs) | New NPs need 3 years under supervision; then independent |
| Texas | Independent, full authority | Restricted—requires physician collaboration indefinitely | Cannot prescribe Schedule II outpatient (except narrow cases) |
| Florida | Independent, full authority | Restricted—requires psychiatrist collaboration | Psych NPs excluded from autonomous practice; must have protocol |
| New York | Independent, full authority | FPA after 3,600 hours (≈2 years) | New NPs need collaboration initially; then independent |
| Pennsylvania | Independent, full authority | Reduced—requires collaboration indefinitely | No independence pathway yet; 30-day Schedule II limit |
| Illinois | Independent, full authority | FPA after 4,000 hours + 250 CE hours | Must have physician collaboration until FPA granted |
The pattern: Psychiatrists have universal prescribing authority. PMHNPs face a patchwork—some states grant independence after experience, others require lifelong supervision. If you’re an NP considering telehealth, your state’s scope-of-practice law will determine whether you can see patients solo or need a collaborating physician.
Short answer: Yes, for most payers in 2026.
Medicare has permanently allowed telehealth for mental health services (with a minor requirement of an in-person visit every 12 months, currently paused). Reimbursement rates are the same whether you see a patient in-office or via video:
NPs get paid at 85% of physician rates when billing under their own NPI for Medicare. Some private insurers pay NPs at parity with MDs, others follow the 85% rule—it depends on your contracts.
State parity laws have strengthened telehealth reimbursement. Illinois, California, and New York all require private insurers to cover telehealth at the same rate as in-person for behavioral health. Texas doesn’t mandate parity, but most insurers voluntarily pay equally given the demand for tele-mental health.
Audio-only visits: Medicare and some states now reimburse for phone-based medication management for mental health, recognizing that not all patients have video access. This is a big win for equity and access.
Let’s talk about what it actually costs to acquire patients as a psychiatrist or PMHNP.
DIY marketing is expensive and slow. If you’re trying to build a practice through Google Ads, SEO, or directory listings:
Total all-in cost: Most solo providers spend $3,000–$5,000/month on marketing channels with uncertain results. Factor in staff time to handle and qualify leads, no-show rates from cold leads, and failed campaigns, and the true cost per acquired patient is easily $200–$500+.
Klarity Health’s model eliminates that risk. You pay a standard listing fee per new patient lead—only when a qualified patient books with you. No upfront marketing spend. No wasted ad budget on clicks that don’t convert. No monthly subscription fees eating into your revenue whether you see patients or not.
The value props:
Instead of gambling $5,000/month on marketing, you get guaranteed ROI: every dollar you spend brings a real patient to your practice.
For psychiatrists and PMHNPs scaling a telehealth practice, that’s the difference between sustainable growth and bleeding cash on unproven channels.
For Psychiatrists:
For PMHNPs (in states requiring collaboration):
Can I prescribe Adderall or Xanax to a new patient via telehealth in 2026?
Yes, under the current federal DEA waiver (extended through December 31, 2025). You must conduct a thorough audio-visual telehealth exam and comply with state-specific requirements (PMP checks, licensure, etc.). Monitor DEA announcements for rule changes that could affect this in late 2024/2025.
Do I need to see telehealth patients in person eventually?
It depends. Medicare requires an in-person visit for tele-mental health patients at least every 12 months (though this is currently paused). Some states have no such requirement. Check your payer contracts and state telehealth laws.
Can PMHNPs prescribe controlled substances independently?
Only in full practice authority states (and only after meeting experience requirements in transition states like NY and IL). In restricted states like Texas, Florida, and Pennsylvania, PMHNPs need physician collaboration and may face limits on Schedule II prescribing.
What happens if the DEA revokes the telehealth waiver?
If the DEA reimpose in-person requirements for controlled substances, you’d need to see new patients face-to-face before prescribing Schedule II–V drugs (or rely on exceptions like 30-day emergency scripts or referrals from in-person providers). Existing patients could likely continue via telehealth. This is why monitoring federal policy is critical.
Do private insurers pay the same for telehealth as in-person?
In most states, yes. Over half of states have telehealth parity laws requiring equal payment for behavioral health services. Medicare pays the same for telehealth as in-office for psychiatric medication management.
Can I practice telepsychiatry across state lines?
Only if you hold a valid license in each state where your patients are located. The Interstate Medical Licensure Compact (IMLC) helps expedite multi-state licensure—TX, PA, and IL are members; CA, NY, and FL are not.
What if I’m an NP in a restricted state—can I still do telehealth?
Yes, but you’ll need a collaborating physician in that state. Some telehealth platforms (like Klarity) provide physician oversight as part of their infrastructure, which can simplify compliance.
Telepsychiatry has gone from stopgap to standard practice. The regulatory landscape is stabilizing, with strong reimbursement parity and (for now) permissive controlled substance rules. But the devil is in the details—state scope-of-practice laws, PMP requirements, and evolving federal policy all matter.
For psychiatrists: You have broad authority. Use it wisely. Stay compliant with state licensure and PMP checks, document thoroughly, and monitor DEA rule changes.
For PMHNPs: Know your state’s scope-of-practice laws inside and out. If you’re in a restricted state, find a collaborative partner who understands telehealth. If you’re in a transition state, rack up those supervised hours and claim your independence.
For both: Platforms like Klarity Health remove the patient acquisition headache—no DIY marketing, no wasted ad spend, no subscription fees. You pay per qualified patient lead, and you get built-in infrastructure to deliver care. That’s how you scale a sustainable telehealth practice in 2026.
Ready to join a network that handles the patient flow while you focus on clinical care? Explore Klarity Health’s provider platform and see how you can build a thriving telepsychiatry practice without the marketing gamble.
| Source & URL | Type of Source | Published/Updated | Reliability |
|---|---|---|---|
| Texas Board of Nursing – APRN Practice FAQ (www.bon.texas.gov) | Official state board FAQ | Revised 2021 | High – Primary source for TX NP rules |
| Florida Statutes Chapter 464 & 456 (www.flsenate.gov) | Official state statutes | 2024 compilation | High – Primary legal text for FL telehealth and NP scope |
| California Board of Registered Nursing – AB 890 FAQs (www.rn.ca.gov) | Official state regulatory board | Updated Nov 2023 | High – Primary source on CA NP scope implementation |
| JDSupra Law News – NY NP Independence Article (www.jdsupra.com) | Law firm article | April 13, 2022 | High – Cites NY Education Law changes in 2022 budget |
| Pennsylvania Coalition of Nurse Practitioners – Scope info (www.pacnp.org) | Professional association | Updated 2022 | Medium – Accurate reflection of PA law |
| NursePractitionerLicense.com – Illinois NP limitations (www.nursepractitionerlicense.com) | Educational portal | Updated Feb 12, 2024 | Medium – Consolidates state law on IL’s 4,000hr requirement |
| Center for Connected Health Policy – Texas Telehealth Laws (www.cchpca.org) | Non-profit policy org | Updated Jan 19, 2026 | High – Comprehensive 50-state telehealth law database |
| National Law Review – Telehealth Prescribing Update (natlawreview.com) | Legal news analysis | Aug 15, 2025 | High – Timely analysis with citations to DEA proposals |
| Nixon Peabody Client Alert – NY telemedicine rule (www.nixonpeabody.com) | Law firm client alert | June 18, 2025 | High – Explains NYSDOH final rule on controlled substances |
| Texas Nurse Practitioners Assoc. – DEA Extension News (texasnp.org) | Professional association | Oct 6, 2023 | High – Cites DEA and HHS announcement on teleprescribing |
| TheraThink – Insurance Reimbursement Rates 2026 (therathink.com) | Industry blog (medical billing) | 2026 rates | Medium – Uses CMS data for Medicare rates; reliable for benchmarking |
| Healing Psychiatry Florida – Psychiatrist Shortage by State (www.healingpsychiatryflorida.com) | Healthcare blog | Jan 15, 2026 | Medium – Data-driven analysis quoting official HRSA stats |
| Zivian Health – 2026 NP-Physician Collaboration Roadmap (www.zivianhealth.com) | Industry/Compliance blog | Feb 16, 2026 | Medium – Detailed overview of collaboration laws; aligns with state statutes |
| NursePractitionerOnline.com – NP Practice Authority 2026 (www.nursepractitioneronline.com) | Professional article | Last verified Feb 5, 2026 | Medium – Provides overall trends and recent changes in state scope |
Find the right provider for your needs — select your state to find expert care near you.